Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RISING

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 61
  • 0 comments

FDA approve MESALAMINE

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • April 14, 2025, 08:42 UTC
  • 56
  • 0 comments

FDA approve CAPECITABINE

Comment Full text

COSETTE

  • FDA Approval
  • April 14, 2025, 08:42 UTC
  • 66
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • April 14, 2025, 08:42 UTC
  • 78
  • 0 comments

FDA approve CICLOPIROX

Comment Full text

CIPLA

  • FDA Approval
  • April 14, 2025, 08:42 UTC
  • 64
  • 0 comments

FDA approve PACLITAXEL

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • April 14, 2025, 08:42 UTC
  • 73
  • 0 comments

FDA approve AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 11, 2025, 18:36 UTC
  • 79
  • 0 comments

FDA approve SITAGLIPTIN PHOSPHATE

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • April 11, 2025, 08:43 UTC
  • 79
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

GLAND

  • FDA Approval
  • April 11, 2025, 08:43 UTC
  • 69
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

BIOCON PHARMA

  • FDA Approval
  • April 11, 2025, 08:43 UTC
  • 65
  • 0 comments

FDA approve EVEROLIMUS

Comment Full text
  • Previous
  • 201
  • 202
  • 203
  • 204
  • 205
  • Next

Search

News categories

  • Technical Exchange News(11369)
  • Event(2835)
  • SEC News(205942)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(134655)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin